TP53 and breast carcinoma: Therefore, we evaluated the implementation of our approach using breast cancer in two ways: (1) comparing the accuracy of the model against the highest-performing model reported in the literature, (2) comparing the resulting networks to KEGG pathways and literature that formed the basis for their extraction, paying particular attention to the p53 pathway.